Antibodies Proteins Assays Small Molecules Other Reagents
AdipoGen, Inc.是以免疫学知识和技术为基础的生物技术公司,公司的产品与肥胖症和Ⅱ型糖尿病等代谢疾病密切相关,包括高质量的重组蛋白、抗体和ELISA试剂盒。主要研究方向:炎症免疫:天然免疫、自然杀伤性T细胞(NKT细胞)、T细胞生物学、感染肿瘤研究:细胞死亡研究、药物抗性、生物标记物、血管新生代谢:糖尿病、肥胖症、脂肪因子、动脉粥样硬化性心血管疾病、线粒体功能障碍具体产品类型:Notch信号通道(Notch受体& Notch配体)、内脏脂肪素(Nampt/PBEF)、颗粒蛋白前体、脂联素(ACRP30)、视黄醇结合蛋白4(RBP4)、白介素/炎症研究(IL33/IL17A)、Vaspin、ANGPTLs家族、FGF家族、脂肪因子其他产品(抵抗素/网膜素……) AdipoGen Life Sciences, Inc. (AGLS) consists of two companies, Adipogen SA (Switzerland) (and its branch office Adipogen AG) and Adipogen Corporation (San Diego, USA). The Corporate headquarters is in San Diego, USA and the Operational headquarters is in Liestal, Switzerland. AGLS operates under the brand “AdipoGen Life Sciences” internationally. We focus our efforts on specific areas of the life sciences market around Inflammation & Immune Responses. These scientific areas include inflammasomes, innate immunity, B & T cells immune regulation, neuroinflammation, obesity, immuno-oncology and COVID-19 research.